Navigation Links
Sutro Biopharma Receives the Pantheon 2015 DiNA Outstanding Partner Award by the California Life Sciences Association
Date:11/18/2015

SAN FRANCISCO, Nov. 18, 2015 /PRNewswire/ -- Sutro Biopharma today announced that it was awarded the Outstanding Partner Award, at the California Life Sciences Association (CLSA) annual Pantheon Ceremony 2015 Presenting DiNA Awards.  Late last year, Sutro entered into a broad strategic collaboration and option agreement with Celgene Corporation to discover and develop multi-specific antibodies and antibody drug conjugates (ADCs) in the field of immuno-oncology.  In addition, Sutro entered a multi-target strategic collaboration with EMD Serono (Merck KGaA) to discover and develop antibody drug conjugates (ADCs).  Sutro's cell-free biologics development platforms, Xpress CF and Xpress CF+ are key elements to its strategic collaborations, driving forward the development of next generation immuno-oncology therapeutics. The CLSA has recognized Northern California based Sutro, for its life science achievements throughout the year.

William Newell, chief executive officer of Sutro Biopharma, said, "We are honored to pioneer a new generation of cancer therapeutics with our partners Celgene and EMD Serono. This award recognizes our partnerships as first-rate collaborations designed to achieve the best for patients and health care providers. Our platform and product development efforts bear enormous promise.  These collaborations have worked to accelerate the development of oncology therapeutics, with compelling patient benefit."

About Sutro Biopharma

Sutro Biopharma, Inc., located in South San Francisco, develops best-in-class antibody drug conjugate and multi-specific antibody-based therapeutics for cancer therapy, including Immuno-Oncology therapies. Sutro's discovery and development efforts are driven by our proprietary Xpress CF™ and Xpress CF+™ platforms, a biochemical synthesis system that enables rapid and systematic evaluation of protein structure-activity relationships, as well as rapid and predictable scalability for manufacturing in Sutro's cGMP facility. In addition to developing its own drug candidate pipeline, which is focused on mono- and bi-specific ADCs, Sutro Biopharma is collaborating with select pharmaceutical and biotech companies to discover and develop novel therapeutics.

Media Contacts:

David Schull or Christopher Hippolyte
Russo Partners
(212) 845-4271
(646)942-5634
david.schull@russopartnersllc.com 
chris.hippolyte@russopartnersllc.com


'/>"/>
SOURCE Sutro Biopharma
Copyright©2015 PR Newswire.
All rights reserved


Related biology technology :

1. Sutro Biopharma to Collaborate with University of California, San Francisco (UCSF), a Recombinant Antibody Network (RAN) Member
2. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
3. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
4. Infinata Implements “Clear Quality” Initiative to Optimize Reliability and Usability of Data, Reports and Analysis for Biopharma and Wealth Management Solutions
5. Verified Clinical Trials (VCT) Will Co-Present With SAFE-BioPharma At Bio-IT World April 10th In Boston, MA Exploring Identity Management In eClinical Trials
6. DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia
7. Biotechnology Market (Biopharmacy, Bioservices, Bioagri, Bioindustrial) Is Expected to Reach USD 414.5 Billion Globally in 2017: Transparency Market Research
8. MannKind, Ariad Pharma, Ziopharm Oncology, Galena Biopharma, and Novavax Under StockCalls Microscope
9. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
10. PDL BioPharma Appoints Peter Garcia as Chief Financial Officer
11. Array BioPharma to Present at the Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2018)... (PRWEB) , ... September 05, 2018 , ... Now available ... Systems will be held on Sept. 19, 2018. With a panel of industry leaders ... this exciting event will reveal industry insights from experts in the field. Register ...
(Date:9/7/2018)... Mass. (PRWEB) , ... September 06, 2018 , ... ... medical device compliance and commercialization, is releasing the agenda for its upcoming user ... across life science industries discussing the latest challenges, opportunities, and approaches to regulatory ...
(Date:9/7/2018)... ... September 06, 2018 , ... Akadeum Life Sciences today announced it has appointed ... executive and leader of numerous biotech companies. , He most recently served as ... by Thompson Street Capital in St. Louis, MO. Prior to ISTO, he was ...
(Date:8/31/2018)... ... August 29, 2018 , ... ... both the University of Southampton and the Institute of Industrial Science, the University ... sea can dramatically accelerate the exploration and study of hard to reach deep ...
Breaking Biology Technology:
(Date:8/29/2018)... ... 28, 2018 , ... Today, Bright Computing , a ... Science Technologies has implemented Bright Cluster Manager at the HudsonAlpha Institute for Biotechnology. ... and genetics research institute located in Huntsville, Ala. Its mission is four-fold: genomic ...
(Date:8/26/2018)... ... August 24, 2018 , ... ... in clinical diagnostic laboratories. However, this technology introduces many well-described challenges around ... which leads the South London NHS Genomic Medicine Centre. The Viapath Genetics ...
(Date:8/23/2018)... ... August 22, 2018 , ... Lajollacooks4u is proud to have hosted a variety of ... time. Companies, such as Illumina, Qualcomm, Hewlett Packard, Sequenom and more, have all visited ... teams. , Part of the reason clientele return is due to Lajollacooks4u’s signature ...
Breaking Biology News(10 mins):